GUGGENHEIM CAPITAL LLC - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 149 filers reported holding IMPAX LABORATORIES INC in Q2 2013. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$293,000
-86.0%
15,117
-87.9%
0.00%
-80.0%
Q4 2017$2,087,000
-25.9%
125,363
-9.7%
0.01%
-28.6%
Q3 2017$2,818,000
+4.5%
138,764
-17.1%
0.01%0.0%
Q2 2017$2,696,000
+17.3%
167,468
-7.9%
0.01%
+16.7%
Q1 2017$2,299,000
+18.9%
181,779
+24.6%
0.01%0.0%
Q4 2016$1,934,000
-42.4%
145,928
+2.9%
0.01%
-40.0%
Q3 2016$3,360,000
-12.7%
141,784
+6.2%
0.01%
-16.7%
Q2 2016$3,848,000
-9.5%
133,531
+0.6%
0.01%
-7.7%
Q1 2016$4,250,000
-43.4%
132,730
-24.4%
0.01%
-40.9%
Q4 2015$7,507,000
-7.9%
175,557
-24.2%
0.02%
-12.0%
Q3 2015$8,155,000
+14.2%
231,601
+48.9%
0.02%
+38.9%
Q2 2015$7,140,000
+48.7%
155,490
+51.8%
0.02%
+63.6%
Q1 2015$4,801,000
+571.5%
102,442
+353.8%
0.01%
+450.0%
Q4 2014$715,000
-96.6%
22,573
-96.8%
0.00%
-96.2%
Q2 2014$21,032,000
+7575.9%
701,300
+6649.1%
0.05%
+5200.0%
Q1 2014$274,000
-19.6%
10,391
-23.3%
0.00%0.0%
Q4 2013$341,000
-62.7%
13,553
-69.6%
0.00%
-66.7%
Q3 2013$914,000
+19.3%
44,574
+16.1%
0.00%0.0%
Q2 2013$766,00038,4060.00%
Other shareholders
IMPAX LABORATORIES INC shareholders Q2 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders